Journal of Surgical Research
Volume 153, Issue 1 , Pages 31-38 , 1 May 2009

Effect of Montelukast and MK-886 on Hepatic Ischemia-Reperfusion Injury in Rats

  • Gul Daglar, M.D.

      Affiliations

    • Department of Fourth Surgery, Ankara Numune Education and Research Hospital, Ankara, Turkey
    • Corresponding Author InformationTo whom correspondence and reprint requests should be addressed at Bahadirlar S, 40/8 Kurtulus, 06590 Ankara, Turkey
    • ,
  • Turgut Karaca, M.D.

      Affiliations

    • Department of Fourth Surgery, Ankara Numune Education and Research Hospital, Ankara, Turkey
    • ,
  • Yunus Nadi Yuksek, M.D.

      Affiliations

    • Department of Fourth Surgery, Ankara Numune Education and Research Hospital, Ankara, Turkey
    • ,
  • Ugur Gozalan, M.D.

      Affiliations

    • Department of Fourth Surgery, Ankara Numune Education and Research Hospital, Ankara, Turkey
    • ,
  • Filiz Akbiyik, M.D., Ph.D.

      Affiliations

    • Department of Biochemistry, Hacettepe University School of Medicine, Ankara, Turkey
    • ,
  • Cenk Sokmensuer, M.D.

      Affiliations

    • Department of Pathology, Hacettepe University School of Medicine, Ankara, Turkey
    • ,
  • Bora Gurel, M.D.

      Affiliations

    • Department of Pathology, Hacettepe University School of Medicine, Ankara, Turkey
    • ,
  • Nuri Aydin Kama, M.D.

      Affiliations

    • Department of Fourth Surgery, Ankara Numune Education and Research Hospital, Ankara, Turkey

Received 19 December 2007

References 

  1. Tsung A, Kaizu T, Nakao A, et al. Ethyl pyruvate ameliorates liver ischemia-reperfusion injury by decreasing hepatic necrosis and apoptozis. Transplantation. 2005;79:196
  2. Kang KJ. Mechanism of hepatic ischemia/reperfusion injury and protection against reperfusion injury. Transpl Proc. 2002;34:2659
  3. Schauer RJ, Gerbes AL, Vonier D, et al. Glutathione protects the rat liver against reperfusion injury after prolonged warm ischemia. Ann Surg. 2004;239:220
  4. Clavien PA, Harvey PR, Strasberg SM. Preservation and reperfusion injuries in liver allografts (An overview and synthesis of current studies). Transplantation. 1992;53:957
  5. Matsui N, Fukuishi N, Fukuyama Y, et al. Protective effect of the 5- lipoxygenase inhibitor ardisiaquinone A on hepatic ischemia-reperfusion injury in rats. Planta Med. 2005;71:717
  6. Selzner N, Rudiger H, Graf R, et al. Protective strategies against ischemic injury of the liver. Gastroenterology. 2003;125:917
  7. Kohli V, Selzner M, Madden JF, et al. Endothelial cell and hepatocyte deaths occur by apoptosis after ischemia-reperfusion injury in the rat liver. Transplantation. 1999;67:1099
  8. Topaloglu S, Abbasoglu O, Ayhan A, et al. Antiapoptoic and protective effects of roscovitine on ischemia-reperfusion injury of the rat liver. Liver Int. 2003;23:300
  9. Takamatsu Y, Shimada K, Chijüwa K, et al. Role of leukotrienes on hepatic ischemia/reperfusion injury in rats. J Surg Res. 2004;119:14
  10. Sener G, Sehirli O, Velioglu-Ogunc A, et al. Montelukast protects against renal ischemia/reperfusion injury in rats. Pharmacol Res. 2006;54:65
  11. Titos E, Claria J, Planaguma A, et al. Inhibition of 5-lipoxygenase induces cell growth arrest and apoptosis in rat Kupffer cells: Implications for liver fibrosis. FASEB J. 2003;17:1745
  12. Riccioni G, Ilio C. Advances in therapy with antileukotriene drugs. Ann Clin Lab Sci. 2004;34:379
  13. Daglar G, Kama NA, Atli M, et al. Effect of 5-lipoxygenase inhibition on Kupffer cell clearance capacity in obstructive jaundiced rats. J Surg Res. 2001;96:158
  14. Mihara M, Uchiyama M. Determination of malonaldehyde precursor in tissues by thiobarbituric acid test. Anal Biochem. 1977;86:271
  15. Tietze F. Enzymic method of quantitative determination of nanogram amounts of total and oxidized glutathione: Applications to mammalian blood and other tissues. Anal Biochem. 1969;27:502
  16. Giakoustidis D, Papageorgiou G, Iliadis S, et al. Intramuscular administration of very high dose of α-tocopherol protects liver from severe ıschemia/reperfusion injury. World J Surg. 2002;26:872
  17. Hernandez LA, Grisham MB, Twohig B, et al. Role of neutrophils in ischemia-reperfusion induced microvascular injury. Am J Physiol. 1987;253:699
  18. Jaeschke H, Farhood A, Smith CW. Neutrophils contribute to ischemia-reperfusion injury in rat liver in vivo. FASEB J. 1990;4:3355
  19. Suzuki S, Toledo-Pereyra LH, Rodriquez FJ. Role of neutrophils during the first 24 hours after liver ischemia and reperfusion injury. Transplant Proc. 1994;26:3695
  20. Martel J, Lajeunesse D. Therapeutic role of dual inhibitors of 5- LOX and COX, selective and non- selective non-steroidal anti-inflammatory drugs. Ann Rheum Dis. 2003;62:501
  21. Lehr HA, Guhlmann A, Nolte D, et al. Leukotrienes as mediators in ischemia-reperfusion injury in a microcirculation model in the hamster. J Clin Invest. 1991;87:2036
  22. Glanemann M, Strenziok R, Kuntze R, et al. Ischemic preconditioning and methylprednisolone both equally reduce hepatic I/R injury. Surgery. 2004;135:203
  23. Giakoustidis D, Papageorgiou G, Iliadis S, et al. The protective effect of α-tocopherol and GdCl3 against hepatic ischemia/reperfusion injury. Surg Today. 2006;36:450
  24. Shen S, Zhang Y, Xiang J, et al. Protective effect of curcumin against liver warm ischemia/reperfusion injury in rat model is associated with regulation of heat shock protein and antioxidant enzymes. World J Gastroenterol. 2007;13:1953
  25. Keppler D, Hagmann W, Rapp S, et al. The relation of leukotrienes to liver injury. Hepatology. 1985;5:883
  26. Hughes H, Farhood A, Jaeschke H. Role of Leukotriene B4 in the pathogenesis of hepatic ischemia-reperfusion injury in the rat. Prostaglandins Leukot Essent Fatty Acids. 1992;45:113
  27. Souza DG, Pinho V, Cassali GD, et al. Effect of a BLT receptor antagonist in a model of severe ischemia and reperfusion injury in the rat. Eur J Pharmacol. 2002;440:61
  28. Filos KS, Kirkilesis I, Spiliopouou I, et al. Bacterial translocations, endotoxaemia and apoptosis following Pringle manoeuvre in rats. Injury. 2004;35:35
  29. Goldstein MF, Anoia J, Black M. Montelukast-induced hepatitis. Ann Intern Med. 2004;140:586
  30. Sener G, Sehirli O, Cetinel S, et al. Amelioration of sepsis-induced hepatic and ileal injury in rats by the leukotriene receptor blocker montelukast. Prostaglandins Leukot Essent Fatty Acids. 2005;73:453
  31. Sener G, Kabasakal L, Cetinel S, et al. Leukotriene receptor blocker montelukast protects against burn-induced oxidative injury of the skin and remote organs. Burns. 2005;31:587
  32. Ciceri P, Rabufetti M, Monopoli A, et al. Production of leukotrienes in a model of focal cerebral ischemia in the rat. Br J Pharmacol. 2001;133:1323

PII: S0022-4804(08)00156-X

doi: 10.1016/j.jss.2008.02.052

Journal of Surgical Research
Volume 153, Issue 1 , Pages 31-38 , 1 May 2009

Article Tools

* Image Usage & Resolution